This analysis examines how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.

The analysis assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, smartphone-based testing, artificial intelligence (AI)-powered data interpretation, electronic health record (EHR) integration, and cloud connectivity.

It also evaluates innovation momentum, emerging technologies, funding activity, case studies, patent landscape, and key growth opportunities, and it covers PoC diagnostics adoption across clinical settings, including hospitals, at-home, outpatient clinics, and pharmacies.

• What role do molecular platforms, AI-powered workflows, home-based testing, and connected care models play in driving growth in decentralized diagnostics?
• What opportunities emerge as PoC diagnostics evolve from simple tests into decentralized, connected, and clinically actionable testing platforms?
• How are patent and funding activities shaping the competitive positioning of the companies in the PoC diagnostics ecosystem?